MESA LABORATORIES Reports Earnings Results for FY2024 Q1 as of June 30 2023

August 14, 2023

🌥️Earnings Overview

For the first quarter of fiscal year 2024, MESA LABORATORIES ($NASDAQ:MLAB) reported an increase of 0.4% in total revenue to USD 50.6 million, compared to the same period in the previous year. However, net income decreased from -1.44 million to -0.55 million, as of June 30 2023. The earnings results were released on August 3 2023.

Stock Price

On Thursday, MESA LABORATORIES reported its earnings results for FY2024 Q1 as of June 30, 2023. The company’s stock opened at $127.5 and closed at $132.6, representing an increase of 5.2% from the prior closing price of $126.0. MESA LABORATORIES has seen steady growth in recent quarters, and forecasts that trend to continue in the upcoming quarters. The company has invested heavily in research and development to maintain their competitive edge in the industry, and their commitment to innovation has been rewarded with a strong financial performance. Analysts have credited much of MESA LABORATORIES’ success to their robust portfolio of products and services, which include a wide array of laboratory and laboratory-related products and services.

As a result, many investors have seen the company as a safe bet for long-term growth. MESA LABORATORIES’ strong performance in Q1 is likely to be replicated in the upcoming quarters, and investors are already taking note of the potential for further growth. With a strong balance sheet and an impressive record of financial performance, MESA LABORATORIES is well-positioned to continue delivering high returns for its shareholders. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Mesa Laboratories. More…

    Total Revenues Net Income Net Margin
    219.27 1.82 0.8%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Mesa Laboratories. More…

    Operations Investing Financing
    40.73 -9.54 -41.44
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Mesa Laboratories. More…

    Total Assets Total Liabilities Book Value Per Share
    642.61 254.89 72.01
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Mesa Laboratories are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    21.8% 8.7% 4.1%
    FCF Margin ROE ROA
    16.5% 1.4% 0.9%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    At GoodWhale, we recently conducted an extensive analysis of MESA LABORATORIES‘ wellbeing. After thorough review of the company’s financial and business aspects, we have assigned MESA LABORATORIES a Risk Rating of High. This is due to numerous risk warnings that we have detected in their income sheet, balance sheet, cashflow statement, and non-financial areas. For more details on these risks, please register with us and receive access to our comprehensive report. Here, you can gain insight into the exact nature of the risks we detected and how they can potentially affect MESA LABORATORIES’ future. Our team of experts is also available to provide any additional guidance or recommendations you may need. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    The company’s products include blood gas analyzers, centrifuges, and incubators. Mesa Laboratories Inc’s competitors include CurAegis Technologies Inc, Biome Technologies PLC, PipeHawk PLC.

    – CurAegis Technologies Inc ($LSE:BIOM)

    Biome Technologies PLC is a British biotechnology company based in Southampton. The company’s core business is the development and commercialisation of sustainable technologies for the food, agriculture and energy industries. The company has a market cap of 1.86M and a ROE of -24.52%. The company’s products include anaerobic digestion systems, algal oils, enzymes and biopolymers. The company’s products are used in a variety of applications including food processing, animal feed, waste management and renewable energy.

    – Biome Technologies PLC ($LSE:PIP)

    PipeHawk PLC is a provider of pipe inspection and condition assessment services. The company has a market capitalization of 5.27 million as of 2022 and a return on equity of -3.7%. PipeHawk PLC provides services to a variety of industries including oil and gas, water and sewer, and power generation. The company’s services are used to inspect and assess the condition of pipelines and other infrastructure.

    Summary

    MESA LABORATORIES reported its FY2024 Q1 earnings results on August 3 2023, with total revenue of USD 50.6 million, representing a slight increase of 0.4% year-over-year, while net income was down to USD -0.55 million compared to the -1.44 million from the previous year. Despite the slight decrease in net income, investors reacted positively to the results with the stock price moving up the same day. Investors should analyze MESA LABORATORIES’ financials further before investing in the company in order to evaluate its overall performance and determine whether it is a good investment opportunity.

    Recent Posts

    Leave a Comment